Relmada Therapeutics, Inc. (RLMD): SCHEDULE 13G/A filed May 13, 2026

Form type

SCHEDULE 13G/A

Filing date

May 13, 2026

Accession number

0000919574-26-002929

Filer

Relmada Therapeutics, Inc. (CIK 1553643)